Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

409
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
409
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

281
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
281
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

302
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
302
Actuarial Approach01:20

Actuarial Approach

140
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
140
Survival Curves01:18

Survival Curves

340
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
340

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Folinic Acid Improves Healing of Diabetic Foot Ulcers.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society·2026
Same author

How Does Age at Diagnosis Influence Multiple Myeloma Survival? Empirical Evidence.

Healthcare (Basel, Switzerland)·2025
Same author

Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care.

Cancers·2025
Same author

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

REVIEW AND RECOMMENDATIONS FOR HEALTH INFORMATICS IN SUB-SAHARAN AFRICAN COUNTRIES: BETWEEN OPPORTUNITIES AND CHALLENGES.

Medical research archives·2025
Same author

Bilateral Germ Cell Tumor of the Testis: Biological and Clinical Implications for a Stem Versus Genetic Origin of Cancers.

Cells·2025
Same journal

Correction: Haddock et al. <i>Imagine the Possibilities Pain Coalition</i> and Opioid Marketing to Veterans: Lessons for Military and Veterans Healthcare. <i>Healthcare</i> 2025, <i>13</i>, 434.

Healthcare (Basel, Switzerland)·2026
Same journal

Macro Responsibility in the Microvascular World: Nurse Experiences in Flap Care, a Phenomenological Study.

Healthcare (Basel, Switzerland)·2026
Same journal

Agreement Between Standing Eight-Point Multifrequency Bioelectrical Impedance Analysis and Dual-Energy X-Ray Absorptiometry for Body Composition Assessment in Apparently Healthy Greek Adults.

Healthcare (Basel, Switzerland)·2026
Same journal

'It's Not About the Food'-Understanding the Lived Experience of Patients Who Developed Hospital-Acquired Malnutrition (HAM) and That of Their Carers.

Healthcare (Basel, Switzerland)·2026
Same journal

Unveiling the Humanizing and Therapeutic Values of Live Music in Healthcare Settings: A Scoping Review.

Healthcare (Basel, Switzerland)·2026
Same journal

Respiratory Rehabilitation and Decannulation in Adults with Prolonged Mechanical Ventilation After Tracheostomy: A Narrative Review.

Healthcare (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Sep 18, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

381

Start Time End Time Integration (STETI): Method for Including Recent Data to Analyze Trends in Kidney Cancer

Thobani Chaduka1, Daniel Berleant1, Michael A Bauer2

  • 1Department of Information Science, University of Arkansas at Little Rock, 2801 S. University Ave., Little Rock, AR 72204, USA.

Healthcare (Basel, Switzerland)
|June 26, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces STETI, a novel survival estimation approach that combines diagnosis and death year cohorts to overcome right censoring. STETI enables more accurate survival trend analysis, crucial for advancing cancer research and treatment planning.

Keywords:
STETIcancerkidneysurvivaltreatmenttrend

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

201
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K

Related Experiment Videos

Last Updated: Sep 18, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

381
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

201
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K

Area of Science:

  • Oncology
  • Biostatistics
  • Survival Analysis

Background:

  • Accurate survival time estimation is vital for clinical decisions and resource allocation.
  • Right censoring in recent diagnosis cohorts biases survival averages downward, hindering timely analysis.
  • Traditional methods struggle to incorporate the most recent survival data due to censoring.

Purpose of the Study:

  • To introduce STETI (Survival Estimation using Time-integrated data), a hybrid approach for survival estimation.
  • To address the challenge of right censoring in recent diagnosis cohorts.
  • To enable more accurate and up-to-date survival trend analyses.

Main Methods:

  • STETI integrates survival data from both diagnosis year cohorts and death year cohorts.
  • Leverages recent survival data often excluded by traditional methods due to right censoring.
  • Tested using SEER data for kidney cancer, applying linear and exponential models.

Main Results:

  • Incorporating death year cohorts effectively mitigates right censoring bias from recent diagnosis cohorts.
  • STETI facilitates survival trend analysis that accounts for recent therapeutic advancements.
  • Demonstrated the method's ability to derive survival time trends from previously underutilized data.

Conclusions:

  • Improved survival estimation supports personalized treatment, healthcare benchmarking, and cancer subtype research.
  • STETI offers a hybrid analytical solution to a significant source of right censoring.
  • The STETI approach, validated in kidney cancer, has broad applicability in oncology and beyond.